Lupus is easy with a little practice - Professor ... - Parkside Hospital
Lupus is easy with a little practice - Professor ... - Parkside Hospital
Lupus is easy with a little practice - Professor ... - Parkside Hospital
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Lupus</strong> <strong>is</strong> <strong>easy</strong>With a <strong>little</strong> <strong>practice</strong><strong>Professor</strong> John Axford DSc MD FRCP FRCPCHSt George’s University of LondonLondon Rheumatology Clinic
Autoimmune rheumaticd<strong>is</strong>eases– Rheumatoid arthrit<strong>is</strong>: RhF, anti-CCP Arthrit<strong>is</strong>– Sjogren’s syndrome: anti-Ro/La Dryness– Vasculit<strong>is</strong> syndromes: c- & p-ANCA– Myosit<strong>is</strong>: Jo-1 Weakness– Systemic scleros<strong>is</strong>:SCL-70 scleoderma
<strong>Lupus</strong>– Multi-systemic d<strong>is</strong>ease– Wide spectrum of clinical manifestations– Exacerbations and rem<strong>is</strong>sions– Constellation of autoantibodies
<strong>Lupus</strong>• Epidemiology– 1/1000 - 1/6000– age: 25 - 35 years– Sex: Females 90%– Race: Afro Caribbean are commonlyaffected
What Does <strong>Lupus</strong> Look Like?
<strong>Lupus</strong>• Skin– Malar butterfly rash– Patchy alopecia– Oral/vaginal ulceration– Periungual erythema– Angioedema– Cutaneous vasculit<strong>is</strong>
<strong>Lupus</strong>• Musculoskeletal– Myalgia– Symmetrical arthrit<strong>is</strong>– Jacoud’s
<strong>Lupus</strong>• Renal– <strong>Lupus</strong> Nephrit<strong>is</strong> 50%Broad spectrum of severity–Hypertension–Renal failure
<strong>Lupus</strong>• Nerves Neuropsychiatric SLE– Peripheral– Central– Diffuse
Compar<strong>is</strong>on Of NPSLE vs MST2 Weighted ImagesCuadadro MJ et al; Medicine (Baltimore) 2000;70:57-68
MR Imaging and Spectroscopy of an NPSLE PatientABmI+37%tCrNAA-16%tCholipids4 3 2 1 0CmI+36%tCrNAA-26%tChoA) T 2 weighted axial image of a 60yr femalepatient <strong>with</strong> NPSLEB) 1 H spectrum from a parietal white matterlesionC) 1 H spectrum from a region of normalappearing occipital white matter.lipids4 3 2 1 0
An<strong>is</strong>otropy Map• Bright pixels - high an<strong>is</strong>otropy• Shows white matter• Quantitative
<strong>Lupus</strong>• Blood– Haemolytic anaemia– Neutropenia– Antiphospholipid Syndrome
<strong>Lupus</strong>• Heart and Circulation– Raynaud’s phenomenon– Pericardit<strong>is</strong>– Myocardit<strong>is</strong>– Endocardit<strong>is</strong>
<strong>Lupus</strong>• Lungs– Plural Effusion– Loss of lung volume
<strong>Lupus</strong>• Eyes– Sjögren’s syndrome– Ep<strong>is</strong>clerit<strong>is</strong>– Retinal infarcts– Optic neurit<strong>is</strong>
<strong>Lupus</strong>• General management– Sun protection– Diet and nutrition:– Unsaturated fatty acids– Exerc<strong>is</strong>e– Smoking cessation:– Increased r<strong>is</strong>k– More active d<strong>is</strong>ease– Immunizations:Influenza & Pneumococcal vaccine
<strong>Lupus</strong>• Immun<strong>is</strong>ation in SLE– Safe and useful– Influenza, Tetanus and pneumococcalvaccine– Prevent infection and associated flare– Live vaccine contraindicated ifimmunosuppressed
<strong>Lupus</strong>Immunosuppressivemedication• Corticosteroid• Hydroxychloroquine
<strong>Lupus</strong>Immunosuppressivemedication• Methotrexate• Cyclophosphamide• Azathioprine• Mycophenolate• Rituximab• Belimumab
<strong>Lupus</strong>• Belimumab• Monoclonal antibody that inhibits thebiological activity of B cell survival factor– B lymphocyte stimulator or BLyS.• Data indicate may be useful for patients <strong>with</strong>active musculoskeletal or cutaneous d<strong>is</strong>ease.
<strong>Lupus</strong>Treating co-morbid conditions:• <strong>Lupus</strong> patients have increased r<strong>is</strong>ks of:– accelerated atheroscleros<strong>is</strong>– pulmonary hypertension– Thrombos<strong>is</strong>: anti-phospholipid antibodies– osteopenia/osteoporos<strong>is</strong>
<strong>Lupus</strong>• Is cancer r<strong>is</strong>k increased in lupus: YES– Non- Hodgkin’s and Hodgkin’s lymphoma– Lung cancer: smoking <strong>is</strong> a predictor– Breast cancer– Squamous skin cancer– Cervical cancer– Vaginal and vulval cancer
<strong>Lupus</strong>Radiation therapy:• Anecdotal reports of increase toxicity during radiationtherapy• Little data to support• If required radiation therapy may be used to treatmalignant d<strong>is</strong>ease
<strong>Lupus</strong>Dhydroepiandrosterone (DHEA)• <strong>Lupus</strong> patients have low levels of DHEA.• Replacement– Data indicates no effect on d<strong>is</strong>ease activity– May improve overall well-being.– Side effects: acne, hair growth, menstrual changes.– Not recommended.
<strong>Lupus</strong>• Avoidance of specific medication:– Sulphur-containing antibiotics may causeexacerbations– Drugs that cause drug-induced lupus• Procainamide, Hydralazine & Minocycline– do not cause exacerbations.
<strong>Lupus</strong>• SLE in Pregnancy– Not contraindicated– Fertility rate normal– High spontaneous m<strong>is</strong>carriage 30 - 50%• if antiphospholipid antibodies present– Treatment <strong>with</strong> Predn<strong>is</strong>olone safe
<strong>Lupus</strong>• SLE in PregnancyAdverse outcomes– Neonatal SLE rare• Transient rash• Complete heart block– Prematurity– Still birth– D<strong>is</strong>ease flare
<strong>Lupus</strong>Prognos<strong>is</strong>• Patient survival <strong>with</strong> lupus:– five year survival 1950’s 40%, 1980’s 90%.• Death:– 5 times higher in women than men– 3 times higher black compared <strong>with</strong> to white women– 1 third of deaths between 15 and 44 years
<strong>Lupus</strong>Prognos<strong>is</strong>• Causes of death:– Heart d<strong>is</strong>ease– Non-Hodgkin’s lymphoma– Lung cancer– Infections– Renal d<strong>is</strong>ease• Steroid therapy: considerable morbidity
<strong>Lupus</strong>• Does clinical rem<strong>is</strong>sion occur– Yes– 25% in one study:• at least one treatment-free clinicalrem<strong>is</strong>sion lasting for at least one year• Rem<strong>is</strong>sion however uncommonand frequently not sustained.
The RA Revolution!<strong>Professor</strong> John Axford DSc MD FRCP FRCPCHThe London Rheumatology Clinic
Rheumatoid Arthrit<strong>is</strong>• The bottom line• It can be cured
Clinical H<strong>is</strong>toryMCP Destruction Causing UlnarDeviation of the Digits
Clinical H<strong>is</strong>torySwan Neck Deformity of theForefingers
Clinical H<strong>is</strong>toryProgresive MCPJ & PIPJ synovit<strong>is</strong>
Rheumatoid Arthrit<strong>is</strong>• In the last 10 years• Mr Gateley has NOToperated on any ofmy patients
Rheumatoid Arthrit<strong>is</strong>• So what has happened?• Rheumatolog<strong>is</strong>ts aresmarter• They have biologicdrugs
Rheumatoid Arthrit<strong>is</strong>Management theory/RA revolution• Joint damage begins early• Longer active d<strong>is</strong>ease pers<strong>is</strong>ts
Rheumatoid Arthrit<strong>is</strong>• So why areRheumatolog<strong>is</strong>ts smart?
Rheumatoid Arthrit<strong>is</strong>Complexity• Most common ARD• Multi-system• Immunological abnormalities• Symmetrical joint inflammation• Extra-articular complications
RA looks different in each patient
Rheumatoid Arthrit<strong>is</strong>Typical referral letter:Dear DoctorPlease see Gwyneth……..• Clientele: Pleasant• RA: 3:1 Female• Age 25-35 yearsIe: Childbearing age
Rheumatoid Arthrit<strong>is</strong>They can do two things at the same time• Academic– Think and do tests• Practical– Treat the patient
Academic RheumatoidArthrit<strong>is</strong>Blood Investigations for Polyarthrit<strong>is</strong>• FBC• Acute Phase Reaction• Immunology: RhFactor, CCP antibodies• Viruses: Parvovirus B19• Biochem<strong>is</strong>try: Iron, Urate, ACE• Physiology: Renal, Liver
Academic RheumatoidArthrit<strong>is</strong>Imaging in Polyarthrit<strong>is</strong>– Xray– MRI• Sometimes required– Ultrasound– Scintigraphy– CT
Practical RheumatoidArthrit<strong>is</strong>Management <strong>practice</strong>Week oneDiagnose and treat• Analgesia: Paracetamol, Codydramol, Tramadol• Modify inflammatory events :Diclofenac,Naproxen, Celebrex, Etoricoxib• Corticsteroid: IM and oral• Education: ie talk, booklet, website
Practical Rheumatoid Arthrit<strong>is</strong>Non Drug & Preventative Treatments• Patient education and counselling• Physical Therapy• Occupational Therapy• Nutrition and Dietary Therapy• Modifying R<strong>is</strong>k Factors for Atheroscleros<strong>is</strong>• Bone Protection• Vaccinations
Practical RheumatoidArthrit<strong>is</strong>Management <strong>practice</strong>Week twoConfirm diagnos<strong>is</strong> and treatModify immunological events• D<strong>is</strong>ease modifying drugs• Biological immunosuppression
Chemical D<strong>is</strong>ease Modifying Drugs• Affect d<strong>is</strong>ease process• May not have immediate therapeutic affect• Should be d<strong>is</strong>continued at < 6 months if notbeneficial• Examples– Methotrexate, Leflunomide, Sulphasalazine,Hydroxychloroquine
Rheumatoid Arthrit<strong>is</strong>Biological treatment strategies• TNF inhibition– Soluble receptor antagon<strong>is</strong>ts:• Etanercept• Fusion proteins compr<strong>is</strong>ed of the p75 TNF receptor linked tothe Fc portion of the human IgG1– Monoclonal antibodies:• Infliximab• Adalimumab• Golimumab• Certolizumab– polyethylene glycolated Fab fragment. No Fc portion)
Rheumatoid Arthrit<strong>is</strong>Biological treatment strategies• IL1 inhibition– Cell surface receptor antagon<strong>is</strong>ts:– Recombulent antagon<strong>is</strong>t of IL1 receptor– Anakinra• IL6 inhibition– Cocilizumab – humanized anti-human IL6 receptor antibody• Co-stimulation blockade– Abatacept (CTLA-4 – Ig)– soluble fusion protein compr<strong>is</strong>ing CTLA – 4 and the Fc portion of IgG.Inhibitory signal.• B cell depletion.– Rituximab– Monoclonal anti-CD20 antibody
Rheumatoid Arthrit<strong>is</strong>TB & not TB: latent TB• Anti-TNF therapy associated <strong>with</strong>increased r<strong>is</strong>k of a variety ofinfections including reactivation oflatent TB.• QuantiFeron testPositive– Anti-TB therapy for one month andthen treatment <strong>with</strong> anti-TNF therapy
Rheumatoid Arthrit<strong>is</strong>RA researchScaling new heights…..Now it’s time for a ……
Thank you for your attentionThe London Rheumatology Clinicwww.londonrheumatology.co.uk
<strong>Lupus</strong>• Do you want more?• Or do you want a….
<strong>Lupus</strong>• Antiphospholipid Syndrome– Primary– Secondary: SLE or other autoimmunerheumatic d<strong>is</strong>eases
<strong>Lupus</strong>• Antiphospholipid Syndrome– Vascular Thrombos<strong>is</strong>– Thrombocytopenia– Recurrent spontaneous m<strong>is</strong>carriage– Emboli– Stroke– Bleeding tendency
<strong>Lupus</strong>• Specific Investigations– Antiphospholipid Antibody– <strong>Lupus</strong> anticoagulant (coagulation assay)
<strong>Lupus</strong>• Clinical Management– Low dose Aspirin - 75mg daily– Warfarin - serious thrombolic events– Special attention needs to be given toAPS positive mothers
<strong>Lupus</strong>• Drug Induced <strong>Lupus</strong>– More problem in Women– Uncommon in Afro Caribbean– 25-70% ANA– 25% SLE
<strong>Lupus</strong>• Drug Induced <strong>Lupus</strong> - continued– Procainamide for heart arrhythmias– Phenytoin for hypertension– Primidone for epilepsy– Minocycline for acne
<strong>Lupus</strong>• <strong>Lupus</strong> researchScaling new heights…..No it’s time for a ……
Thank you for your attentionThe London Rheumatology Clinicwww.londonrheumatology.co.uk
Thank you for your attention…
Audience exhaustion!
Thank you for yourattention
Understanding the science(Auto?-) AntigenMonocytes/MacrophagesAutocrineGrowthB&T cells and othersMigrationPannus T<strong>is</strong>sueSynovialFibroblastsTarget:B&T cellsTarget:Cell Adhesion Molecules(CAMs)Target:Inflammatory Cytokines
What sort of arthrit<strong>is</strong>?
More Osteoarthrit<strong>is</strong> ResearchRequired
Please Meet Gwyneth
Osteoarthrit<strong>is</strong>Patient ManagementEvidence based•Importance of a Patient-centredmultid<strong>is</strong>ciplinary approach•Conservative non-drug interventions•Judicious use of drugs•Appropriate surgical referral
………and all the complications
Academic RheumatoidArthrit<strong>is</strong>To Make a Diagnos<strong>is</strong>• H<strong>is</strong>tory• Examination– Symmetrical Arthrit<strong>is</strong>– Rheumatoid Nodules• Investigations– Rheumatoid Factor– Radiography
<strong>Lupus</strong>• SLE in PregnancyAdverse outcomes– Neonatal SLE rare• Transient rash• Complete heart block